To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CYC1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
542 supporting clones for gene CYC1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BU508272 leiomyosarcoma, uterus .a 1 to 462 1 to 462   tiling clone,   462/462
(100 %)
5 diff
(99.0 %id)
BU856793 adenocarcinoma, cell line, breast .a 414 to 1091 1 to 683   tiling clone,   683/927
(73 %)
22 diff
(97.7 %id)
BG328536 adenocarcinoma cell line, colon .a 421 to 1209 1 to 778       778/942
(82 %)
19 diff
(98.0 %id)
BG335674 choriocarcinoma, placenta .a 443 to 1098 1 to 644       644/966
(66 %)
26 diff
(97.4 %id)
CR735564 lymph, lymphoma, cell line .a 444 to 953 39 to 548       510/548
(93 %)
9 diff
(98.4 %id)
NM_001916.3   .a 444 to 1652 1 to 1209 M76V RefSeq, AAA   1209/1209
(100 %)
1 diff
(100.0 %id)
BG336731 choriocarcinoma, placenta .a 445 to 1035 1 to 592       592/894
(66 %)
26 diff
(97.1 %id)
BG760436 melanotic melanoma, high MDR (cell line), skin .a 446 to 1276 1 to 831       831/834
(99 %)
11 diff
(98.7 %id)
BQ061421 lymph, lymphoma, cell line .a 447 to 1036 1 to 598       598/1299
(46 %)
18 diff
(98.7 %id)
BQ066644 lymph, lymphoma, cell line .a 447 to 1038 1 to 594       594/1100
(54 %)
25 diff
(97.8 %id)
DA896448 skeletal muscle .a 449 to 772 2 to 325   capped   324/324
(100 %)
4 diff
(98.8 %id)
BG424767 Kidney, renal cell adenocarcinoma .a 453 to 1259 1 to 811       772/1129
(68 %)
31 diff
(97.3 %id)
BG482814 lung .a 453 to 1208 1 to 761       761/762
(99 %)
18 diff
(97.7 %id)
BG535078 lung .a 453 to 1190 1 to 749       749/754
(99 %)
21 diff
(97.3 %id)
BQ683860 melanotic melanoma, cell line, skin .a 453 to 1096 1 to 646       646/960
(67 %)
10 diff
(99.0 %id)
TI_44342801   .a 453 to 1259 118 to 926       809/953
(84 %)
14 diff
(98.6 %id)
TI_44346004   .a 453 to 1154 73 to 773       701/773
(90 %)
11 diff
(98.6 %id)
BE798757 lung, small cell carcinoma .a 454 to 1258 1 to 808       807/809
(99 %)
22 diff
(97.3 %id)
BM851335 lymph node, stomach .a 454 to 669 1 to 216       216/216
(100 %)
3 diff
(98.7 %id)
BM845445 lymph node, stomach .a 454 to 943 1 to 489       489/489
(100 %)
3 diff
(99.4 %id)
DA893985 skeletal muscle .a 454 to 918 2 to 466   capped   465/465
(100 %)
3 diff
(99.4 %id)
BQ678254 melanotic melanoma, cell line, skin .a 455 to 947 1 to 499       499/1323
(37 %)
30 diff
(97.8 %id)
BF978967 melanotic melanoma, high MDR, skin .a 456 to 1186 1 to 716       716/875
(81 %)
19 diff
(97.9 %id)
BG329162 eye, retinoblastoma .a 456 to 1190 1 to 722       722/938
(76 %)
28 diff
(97.1 %id)
BG530771 embryonal carcinoma, testis .a 456 to 1097 1 to 647       647/882
(73 %)
20 diff
(97.8 %id)
BI544464 brain, hippocampus .a 458 to 1259 1 to 800       800/805
(99 %)
14 diff
(98.3 %id)
CB146119 brain .a 460 to 732 1 to 273       273/273
(100 %)
13 diff
(95.3 %id)
BG771369 adenocarcinoma, Prostate .a 460 to 948 1 to 493       493/1017
(48 %)
20 diff
(98.1 %id)
BI669285 brain, hypothalamus .a 461 to 1154 1 to 694       694/694
(100 %)
8 diff
(98.9 %id)
BE279750 choriocarcinoma, placenta .a 463 to 1147 1 to 689       689/696
(98 %)
18 diff
(97.5 %id)
BG478845 melanotic melanoma, skin .a 463 to 1034 1 to 581       581/581
(100 %)
10 diff
(98.3 %id)
BG530623 embryonal carcinoma, testis .a 463 to 963 1 to 505       505/748
(67 %)
15 diff
(98.0 %id)
BG687404 lung, mucoepidermoid carcinoma .a 463 to 970 1 to 507       507/507
(100 %)
12 diff
(97.7 %id)
BG778180 adenocarcinoma, Prostate .a 463 to 1153 1 to 693       693/693
(100 %)
8 diff
(98.9 %id)
BG778215 adenocarcinoma, Prostate .a 463 to 1265 1 to 813       813/870
(93 %)
33 diff
(96.3 %id)
BM916336 amelanotic melanoma, cell line, skin .a 463 to 738 1 to 274       274/337
(81 %)
23 diff
(93.2 %id)
BQ648181 hepatocellular carcinoma, cell line, Liver .a 463 to 1159 16 to 718       703/932
(75 %)
24 diff
(97.5 %id)
CB998254 placenta, pre-eclamptic placenta .a 463 to 1089 28 to 659       632/785
(80 %)
19 diff
(97.6 %id)
TI_44000585   .a 463 to 1259 132 to 926       795/931
(85 %)
16 diff
(98.3 %id)
AK026633   .a 464 to 1652 1 to 1189 M76V available from FLJ, AAA   1189/1189
(100 %)
2 diff
(99.9 %id)
CB156418 brain .a 464 to 909 1 to 446       446/446
(100 %)
2 diff
(99.6 %id)
CN369445 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 464 to 948 1 to 485       485/485
(100 %)
7 diff
(98.6 %id)
AI969899 Prostate .a 464 to 898 1 to 435     Submitted on the opposite strand 435/435
(100 %)
7 diff
(98.4 %id)
BF240637 bone marrow, from acute myelogenous leukemia .a 464 to 1098 1 to 625       625/910
(68 %)
46 diff
(95.0 %id)
BM845478 lymph node, stomach .a 464 to 908 1 to 445       445/445
(100 %)
2 diff
(99.6 %id)
BE410426 choriocarcinoma, placenta .a 465 to 1222 1 to 757       757/794
(95 %)
22 diff
(97.3 %id)
BG501586 embryonal carcinoma, testis .a 465 to 1187 1 to 725       725/725
(100 %)
10 diff
(98.7 %id)
BG502532 embryonal carcinoma, testis .a 465 to 1098 1 to 646       646/709
(91 %)
19 diff
(97.4 %id)
BE549599 carcinoid, lung .a 466 to 1025 1 to 561     Submitted on the opposite strand 561/561
(100 %)
4 diff
(99.3 %id)
BF973009 leiomyosarcoma cell line, uterus .a 466 to 1256 1 to 816       788/1028
(76 %)
62 diff
(94.0 %id)
BG325743 Kidney, renal cell adenocarcinoma .a 466 to 1098 1 to 629       629/635
(99 %)
7 diff
(98.9 %id)
BG746370 adenocarcinoma cell line, colon .a 466 to 1024 1 to 559       559/561
(99 %)
3 diff
(99.5 %id)
BG832252 epithelioid carcinoma cell line, Pancreas .a 466 to 1259 1 to 796       796/801
(99 %)
17 diff
(97.9 %id)
BG830616 epithelioid carcinoma cell line, Pancreas .a 466 to 1257 1 to 790       790/940
(84 %)
24 diff
(97.5 %id)
BI667120 brain, hypothalamus .a 466 to 1259 6 to 802       797/829
(96 %)
13 diff
(98.5 %id)
BM424278 amelanotic melanoma, cell line, skin .a 466 to 1070 1 to 607       607/1058
(57 %)
16 diff
(98.5 %id)
TI_57190705   .a 466 to 1190 53 to 803       748/972
(76 %)
51 diff
(94.8 %id)
BM846024 lymph node, stomach .a 466 to 885 1 to 421       421/421
(100 %)
4 diff
(99.1 %id)
BI259106 cervical carcinoma cell line, cervix .a 467 to 1097 1 to 647       647/801
(80 %)
27 diff
(96.7 %id)
BI859411 breast, mammary adenocarcinoma, cell line .a 467 to 1082 1 to 637       637/971
(65 %)
38 diff
(96.1 %id)
BU557946 adenocarcinoma, cell line, breast .a 467 to 1105 1 to 647       647/1017
(63 %)
24 diff
(97.7 %id)
BG421287 Kidney, renal cell adenocarcinoma .a 468 to 1259 1 to 779       779/891
(87 %)
33 diff
(96.3 %id)
BM464754 lymph, lymphoma, cell line .a 468 to 785 1 to 318       318/1210
(26 %)
9 diff
(99.3 %id)
BU931281 ovary, teratocarcinoma, cell line .a 468 to 1089 1 to 628       628/853
(73 %)
19 diff
(97.8 %id)
CB994321 placenta, pre-eclamptic placenta .a 468 to 1096 24 to 658       635/820
(77 %)
24 diff
(97.1 %id)
CB140879 Liver .a 468 to 873 1 to 406       406/406
(100 %)
7 diff
(98.3 %id)
EL949147 eyeball .a 469 to 1036 1 to 568       568/568
(100 %)
4 diff
(99.3 %id)
BF971750 leiomyosarcoma cell line, uterus .a 469 to 1079 1 to 606       606/613
(98 %)
12 diff
(98.1 %id)
BG339674 leiomyosarcoma cell line, uterus .a 469 to 1188 1 to 710   AAA   710/975
(72 %)
24 diff
(97.6 %id)
BG740435 skin .a 469 to 1218 1 to 753       753/753
(100 %)
7 diff
(99.1 %id)
DN601909 human embryonic stem cells .a 469 to 1031 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
BM764140 myeloma .a 469 to 774 1 to 307       307/307
(100 %)
3 diff
(99.1 %id)
BM846799 myeloma .a 469 to 1031 1 to 561       561/561
(100 %)
6 diff
(99.0 %id)
BM846588 myeloma .a 469 to 946 1 to 476       476/476
(100 %)
5 diff
(99.0 %id)
CN369442 embryonic stem cells, DMSO-treated H9 cellline .a 470 to 953 1 to 484       484/484
(100 %)
6 diff
(98.8 %id)
BM083861 lung, small cell carcinoma .a 470 to 1195 20 to 746       727/746
(97 %)
12 diff
(98.4 %id)
BM424137 amelanotic melanoma, cell line, skin .a 470 to 1238 1 to 782       782/1074
(72 %)
8 diff
(99.3 %id)
CB215041 normal endometrium, late proliferativephase, cycle day 13, uterus .a 470 to 1003 1 to 534       534/534
(100 %)
2 diff
(99.7 %id)
AU099970   .a 470 to 769 1 to 300       300/300
(100 %)
8 diff
(97.4 %id)
BP273677   .a 470 to 1025 1 to 556       556/556
(100 %)
8 diff
(98.6 %id)
DN991812 brain, whole brain .a 470 to 1156 7 to 693       687/693
(99 %)
2 diff
(99.8 %id)
TI_154189551   .a 470 to 1410 50 to 974       929/1034
(89 %)
31 diff
(97.1 %id)
CN369444 embryonic stem cells, DMSO-treated H9 cellline .a 471 to 948 1 to 478       478/478
(100 %)
2 diff
(99.6 %id)
CN369446 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 471 to 1072 1 to 602       602/602
(100 %)
2 diff
(99.7 %id)
BE856429 brain, glioblastoma (pooled) .a 471 to 979 1 to 509     Submitted on the opposite strand 509/509
(100 %)
9 diff
(98.3 %id)
BG740860 skin .a 471 to 1352 1 to 881       881/884
(99 %)
15 diff
(98.4 %id)
BG741838 skin .a 471 to 1240 1 to 769       769/769
(100 %)
12 diff
(98.5 %id)
BG778433 adenocarcinoma, Prostate .a 471 to 1222 1 to 750       750/754
(99 %)
19 diff
(97.5 %id)
BM450096 melanotic melanoma, skin .a 471 to 932 1 to 463       463/1434
(32 %)
13 diff
(99.1 %id)
BU599378 mixed (pool of 40 RNAs) .a 471 to 959 1 to 496       496/934
(53 %)
28 diff
(97.1 %id)
CD558237 White Matter .a 471 to 989 26 to 545       520/1001
(51 %)
20 diff
(98.1 %id)
CF126545 Chondrosarcoma Lung Metastasis cell lines, lung .a 471 to 1279 1 to 808       808/808
(100 %)
8 diff
(99.1 %id)
BM831599 lymph node, stomach .a 471 to 826 1 to 356       356/358
(99 %)
4 diff
(98.9 %id)
DA893203 skeletal muscle .a 471 to 918 2 to 449   capped   448/453
(98 %)
3 diff
(99.4 %id)
DA893205 skeletal muscle .a 471 to 849 2 to 381   capped   380/380
(100 %)
4 diff
(99.0 %id)
AA314979 colon .a 472 to 929 1 to 454       454/454
(100 %)
6 diff
(98.7 %id)
BP264444 small intestine .a 472 to 1013 1 to 542       542/554
(97 %)
22 diff
(96.1 %id)
BF027427 melanotic melanoma, skin .a 472 to 1259 1 to 784       784/839
(93 %)
27 diff
(96.8 %id)
BF342554 brain, glioblastoma with EGFR amplification .a 472 to 1256 1 to 781       781/984
(79 %)
22 diff
(97.8 %id)
BG426642 Kidney .a 472 to 1188 1 to 726       722/923
(78 %)
62 diff
(93.3 %id)
BG683222 brain, neuroblastoma, cell line .a 472 to 1189 1 to 718   fully sequenced,   718/718
(100 %)
7 diff
(99.1 %id)
BI084056 epidermoid carcinoma, cell line, salivary gland .a 472 to 970 1 to 499   fully sequenced,   499/499
(100 %)
2 diff
(99.6 %id)
BM562948 astrocytoma grade IV, cell line, brain .a 472 to 994 1 to 524       524/1196
(43 %)
10 diff
(99.2 %id)
BQ227729 epithelioid carcinoma, Pancreas .a 472 to 972 1 to 501       501/1045
(47 %)
9 diff
(99.2 %id)
BU172937 eye, retinoblastoma .a 472 to 1002 1 to 533       531/923
(57 %)
18 diff
(98.1 %id)
DA006661   .a 473 to 1043 2 to 572   capped   571/571
(100 %)
2 diff
(99.7 %id)
AW248381 lung, small cell carcinoma .a 473 to 984 1 to 512       512/512
(100 %)
5 diff
(99.1 %id)
BE734963 choriocarcinoma, placenta .a 473 to 1168 27 to 729       703/1028
(68 %)
45 diff
(95.7 %id)
BM810578 astrocytoma grade IV, cell line, brain .a 473 to 1016 1 to 547       547/1225
(44 %)
14 diff
(98.9 %id)
BQ644409 hepatocellular carcinoma, cell line, Liver .a 473 to 996 1 to 527       527/1202
(43 %)
8 diff
(99.4 %id)
BQ919477 large cell carcinoma, lung .a 473 to 949 1 to 480       480/1059
(45 %)
16 diff
(98.5 %id)
BQ940967 large cell carcinoma, lung .a 473 to 1191 1 to 729       729/862
(84 %)
20 diff
(97.7 %id)
BQ924632 large cell carcinoma, lung .a 473 to 1296 1 to 830       830/895
(92 %)
11 diff
(98.8 %id)
BQ933839 large cell carcinoma, lung .a 473 to 1106 1 to 637       637/969
(65 %)
20 diff
(98.0 %id)
CX785972 human embryonic stem cells .a 473 to 1182 1 to 709       709/709
(100 %)
3 diff
(99.6 %id)
DB190419 lung, tumor tissue .a 473 to 1065 2 to 595   capped   594/594
(100 %)
4 diff
(99.4 %id)
DB489887 hypothalamus .a 474 to 915 1 to 443       443/443
(100 %)
3 diff
(99.4 %id)
DB505383 hypothalamus .a 474 to 937 1 to 464       464/464
(100 %)
2 diff
(99.6 %id)
BF027699 melanotic melanoma, skin .a 474 to 1299 28 to 867       840/1038
(80 %)
49 diff
(95.3 %id)
BM559924 amelanotic melanoma, cell line, skin .a 474 to 1034 23 to 585       563/1257
(44 %)
33 diff
(97.4 %id)
BG334762 melanotic melanoma, skin .a 475 to 1096 1 to 623       623/781
(79 %)
27 diff
(96.6 %id)
BM457316 embryonal carcinoma, cell line, testis .a 475 to 793 1 to 317       317/1177
(26 %)
9 diff
(99.3 %id)
BQ059281 lymph, lymphoma, cell line .a 475 to 1159 1 to 689       689/921
(74 %)
10 diff
(99.0 %id)
BQ061575 lymph, lymphoma, cell line .a 475 to 1070 1 to 598       598/1291
(46 %)
10 diff
(99.3 %id)
BQ687335 ductal carcinoma, cell line, Pancreas .a 475 to 1259 1 to 789       789/908
(86 %)
11 diff
(98.8 %id)
BQ897848 epidermoid carcinoma, cell line, salivary gland .a 475 to 945 1 to 471       471/1061
(44 %)
14 diff
(98.7 %id)
BM843853 lymph node, stomach .a 475 to 879 1 to 406       406/408
(99 %)
4 diff
(99.1 %id)
BM691628 eye, RPE and Choroid .a 475 to 946 1 to 472       472/472
(100 %)
4 diff
(99.2 %id)
BC001006 Lung, small cell carcinoma .a 476 to 1652 1 to 1177 M76V available from MGC, AAA   1177/1177
(100 %)
3 diff
(99.8 %id)
BF206158 brain, neuroblastoma .a 476 to 1225 1 to 746       746/1134
(65 %)
19 diff
(98.4 %id)
CN369437 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 477 to 1088 1 to 612       612/612
(100 %)
2 diff
(99.7 %id)
BI257055 cervical carcinoma cell line, cervix .a 477 to 1188 1 to 734       734/902
(81 %)
48 diff
(94.7 %id)
CT002112 T-Lymphocytes .a 477 to 807 1 to 332       332/332
(100 %)
6 diff
(98.2 %id)
TI_154193033   .a 477 to 1259 50 to 831       782/1006
(77 %)
8 diff
(99.3 %id)
BM810464 astrocytoma grade IV, cell line, brain .a 478 to 942 23 to 487       465/1226
(37 %)
20 diff
(98.4 %id)
BM915789 amelanotic melanoma, cell line, skin .a 478 to 1229 21 to 776       756/1067
(70 %)
32 diff
(97.1 %id)
BU944037 adenocarcinoma, cell line, breast .a 478 to 1223 1 to 754       754/1003
(75 %)
16 diff
(98.5 %id)
CF127512 Chondrosarcoma Lung Metastasis cell lines, lung .a 478 to 1245 1 to 767       767/767
(100 %)
5 diff
(99.4 %id)
EL951163 eyeball .a 479 to 995 1 to 517       517/517
(100 %)
7 diff
(98.7 %id)
BQ777056 Pancreas, Purified pancreatic islet .a 479 to 1035 1 to 557       557/557
(100 %)
1 diff
(99.9 %id)
BU153854 epithelioid carcinoma, Pancreas .a 479 to 1042 1 to 564       564/926
(60 %)
24 diff
(97.5 %id)
CD518453 White Matter .a 479 to 948 1 to 472       472/1207
(39 %)
11 diff
(99.1 %id)
CR984441 T-Lymphocytes .a 479 to 918 1 to 440       440/442
(99 %)
8 diff
(98.2 %id)
BM792613 Ascites, stomach .a 479 to 1148 1 to 670       670/670
(100 %)
2 diff
(99.8 %id)
X06994   .a 479 to 1652 1 to 1173 M76V L89V     1173/1173
(100 %)
4 diff
(99.7 %id)
CN369438 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 480 to 1166 1 to 687       687/687
(100 %)
1 diff
(99.9 %id)
AW161282 brain, frontal lobe .a 480 to 941 1 to 462       462/500
(92 %)
29 diff
(94.2 %id)
BF689784 melanotic melanoma, high MDR (cell line), skin .a 480 to 985 1 to 509   fully sequenced,   509/509
(100 %)
2 diff
(99.7 %id)
BU951636 Pancreas, Purified pancreatic islet .a 480 to 719 1 to 240       240/241
(99 %)
3 diff
(98.8 %id)
BU540849 epithelioid carcinoma cell line, Pancreas .a 480 to 902 1 to 428       428/873
(49 %)
10 diff
(98.9 %id)
BU541834 carcinoma, cell line, Prostate .a 480 to 1293 26 to 842       817/936
(87 %)
13 diff
(98.7 %id)
TI_57192164   .a 480 to 1298 121 to 939       819/819
(100 %)
6 diff
(99.3 %id)
CB106865 Liver .a 480 to 812 1 to 333       333/338
(98 %)
7 diff
(98.0 %id)
AA579909 colon, colon tumor RER+ .a 481 to 946 1 to 459     Submitted on the opposite strand 459/470
(97 %)
57 diff
(87.9 %id)
BF315891 brain, neuroblastoma .a 481 to 1344 1 to 869       869/1056
(82 %)
40 diff
(96.3 %id)
BF683183 leiomyosarcoma cell line, uterus .a 481 to 1266 1 to 781       781/858
(91 %)
27 diff
(96.9 %id)
BF983695 duodenal adenocarcinoma, cell line, small intestine .a 481 to 1196 1 to 720       720/958
(75 %)
16 diff
(98.4 %id)
BG104379 melanotic melanoma, skin .a 481 to 1259 1 to 776       776/903
(85 %)
24 diff
(97.4 %id)
BG425619 Kidney, renal cell adenocarcinoma .a 481 to 1163 1 to 682       682/682
(100 %)
7 diff
(99.0 %id)
BG479889 choriocarcinoma, placenta .a 481 to 1193 1 to 713       713/713
(100 %)
5 diff
(99.3 %id)
BI861223 breast, mammary adenocarcinoma, cell line .a 481 to 1298 1 to 818       818/818
(100 %)
6 diff
(99.3 %id)
BM559338 amelanotic melanoma, cell line, skin .a 481 to 1358 1 to 883       883/991
(89 %)
17 diff
(98.3 %id)
BM460432 eye, retinoblastoma .a 481 to 950 1 to 470       470/1330
(35 %)
12 diff
(99.1 %id)
TI_44384908   .a 481 to 1344 98 to 965       868/869
(99 %)
25 diff
(97.2 %id)
BC015616 Skin, melanotic melanoma, high MDR. .a 482 to 1652 1 to 1171 M76V available from MGC, AAA   1171/1171
(100 %)
2 diff
(99.9 %id)
BX426852 fetal liver, Liver .a 482 to 849 1 to 366       366/1092
(33 %)
5 diff
(99.6 %id)
CA397919 eye, RPE/choroid .a 482 to 1047 1 to 566       566/566
(100 %)
2 diff
(99.7 %id)
AI914013 colon .a 482 to 911 1 to 432     Submitted on the opposite strand 432/432
(100 %)
9 diff
(98.0 %id)
BE797039 lung, small cell carcinoma .a 482 to 1162 1 to 679       679/701
(96 %)
7 diff
(99.1 %id)
BG675178 skin .a 482 to 1221 1 to 739       739/739
(100 %)
7 diff
(99.1 %id)
BG773724 choriocarcinoma, placenta .a 482 to 973 1 to 492       492/492
(100 %)
3 diff
(99.4 %id)
BM810165 amelanotic melanoma, cell line, skin .a 482 to 1259 1 to 787       787/1155
(68 %)
15 diff
(98.8 %id)
BM455253 lymph, lymphoma, cell line .a 482 to 1325 1 to 842       842/1126
(74 %)
23 diff
(98.0 %id)
BU158205 epidermoid carcinoma, cell line, salivary gland .a 482 to 1259 1 to 789       789/936
(84 %)
14 diff
(98.6 %id)
BQ650634 hepatocellular carcinoma, cell line, Liver .a 482 to 949 1 to 468       468/1038
(45 %)
6 diff
(99.5 %id)
BQ926535 large cell carcinoma, lung .a 482 to 1259 1 to 784       784/906
(86 %)
29 diff
(96.8 %id)
CX786238 human embryonic stem cells .a 482 to 1226 1 to 745       745/745
(100 %)
2 diff
(99.8 %id)
BC020566 Brain, anaplastic oligodendroglioma with1p/19q loss .a 483 to 1652 1 to 1170 M76V available from MGC, AAA   1170/1170
(100 %)
2 diff
(99.9 %id)
AA078744 Pancreas .a 483 to 885 1 to 395       395/397
(99 %)
23 diff
(94.3 %id)
BE410106 choriocarcinoma, placenta .a 483 to 1361 33 to 916       884/955
(92 %)
28 diff
(97.1 %id)
BI554220 anaplastic oligodendroglioma with 1p/19qloss, brain .a 483 to 1344 1 to 866       866/867
(99 %)
25 diff
(97.2 %id)
BU173960 large cell carcinoma, lung .a 483 to 1238 1 to 767       767/896
(85 %)
20 diff
(97.8 %id)
BE792112 lung, small cell carcinoma .a 484 to 1259 1 to 768       768/872
(88 %)
18 diff
(98.0 %id)
BI254519 cervical carcinoma cell line, cervix .a 484 to 1308 1 to 835       835/835
(100 %)
33 diff
(96.1 %id)
BE795035 lung, small cell carcinoma .a 485 to 1335 1 to 846       850/915
(92 %)
33 diff
(96.4 %id)
BM423945 amelanotic melanoma, cell line, skin .a 485 to 1344 1 to 868       868/1076
(80 %)
19 diff
(98.3 %id)
BE791032 lung, small cell carcinoma .a 486 to 1317 1 to 828       828/1017
(81 %)
21 diff
(98.0 %id)
BU931635 ovary, teratocarcinoma, cell line .a 486 to 1197 1 to 724       724/906
(79 %)
33 diff
(96.4 %id)
CR980288 T-Lymphocytes .a 486 to 876 1 to 391       391/391
(100 %)
6 diff
(98.5 %id)
BT019798   .a 487 to 1462 1 to 976   tiling clone,   976/978
(99 %)
1 diff
(99.9 %id)
CR541674   .a 487 to 1464 1 to 978 M76V     978/978
(100 %)
2 diff
(99.8 %id)
TI_1948105721   .a 487 to 970 136 to 619   fully sequenced,   484/619
(78 %)
8 diff
(98.8 %id)
TI_1948121368   .a 487 to 970 135 to 622   fully sequenced,   488/622
(78 %)
13 diff
(98.0 %id)
CN369441 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 488 to 744 1 to 257       257/257
(100 %)
4 diff
(98.5 %id)
BQ228538 melanotic melanoma, skin .a 488 to 1259 1 to 778       778/912
(85 %)
15 diff
(98.4 %id)
CN369439 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 490 to 812 1 to 323       323/324
(99 %)
3 diff
(99.1 %id)
BG575258 breast, mammary adenocarcinoma, cell line .a 490 to 1356 1 to 867       867/933
(92 %)
22 diff
(97.7 %id)
CR982045 T-Lymphocytes .a 490 to 649 1 to 160       160/166
(96 %)
4 diff
(97.6 %id)
TI_1948105542   .a 490 to 970 133 to 612   fully sequenced,   480/612
(78 %)
7 diff
(98.9 %id)
BG285339 adenocarcinoma, cell line, Prostate .a 491 to 1259 1 to 755       755/922
(81 %)
27 diff
(97.1 %id)
BG828906 muscle, rhabdomyosarcoma .a 491 to 1359 1 to 877       877/1072
(81 %)
31 diff
(97.2 %id)
BQ049077 lymph, lymphoma, cell line .a 491 to 1098 1 to 609       609/1090
(55 %)
9 diff
(99.2 %id)
BU157199 melanotic melanoma, cell line, skin .a 491 to 843 1 to 352       352/1059
(33 %)
9 diff
(99.2 %id)
BU956177 adenocarcinoma, cell line, breast .a 491 to 981 1 to 495       493/1045
(47 %)
22 diff
(97.9 %id)
BQ428496 leiomyosarcoma, uterus .a 492 to 1259 1 to 775       775/905
(85 %)
18 diff
(98.1 %id)
BQ952992 carcinoma, cell line, Prostate .a 492 to 932 33 to 473       441/1088
(40 %)
12 diff
(98.9 %id)
CF127579 Chondrosarcoma Lung Metastasis cell lines, lung .a 492 to 1267 1 to 776       776/803
(96 %)
8 diff
(99.1 %id)
TI_154193116   .a 492 to 1360 51 to 911       861/996
(86 %)
17 diff
(98.3 %id)
BU543099 carcinoma, cell line, Prostate .a 493 to 923 1 to 431       431/1060
(40 %)
11 diff
(99.0 %id)
BE794108 lung, small cell carcinoma .a 494 to 1259 1 to 761       761/808
(94 %)
14 diff
(98.3 %id)
BI084110 epidermoid carcinoma, cell line, salivary gland .a 494 to 1315 1 to 836       836/1183
(70 %)
44 diff
(96.3 %id)
BE260423 brain, neuroblastoma .a 495 to 1077 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
BE264775 lung, small cell carcinoma .a 495 to 1067 1 to 572       572/573
(99 %)
4 diff
(99.4 %id)
BE264510 lung, small cell carcinoma .a 495 to 1189 1 to 690       690/714
(96 %)
13 diff
(98.2 %id)
BE277443 melanotic melanoma, skin .a 495 to 1192 1 to 695       695/696
(99 %)
12 diff
(98.3 %id)
BE535259 cervix .a 496 to 1258 1 to 761       761/825
(92 %)
18 diff
(97.9 %id)
BE870848 adenocarcinoma, colon .a 496 to 1259 1 to 755       755/793
(95 %)
16 diff
(98.0 %id)
BE791712 lung, small cell carcinoma .a 496 to 1259 1 to 755       755/851
(88 %)
14 diff
(98.4 %id)
BE791348 lung, small cell carcinoma .a 496 to 1301 1 to 791       795/992
(80 %)
18 diff
(98.2 %id)
BG765870 melanotic melanoma, high MDR (cell line), skin .a 497 to 1337 1 to 846       846/846
(100 %)
17 diff
(98.0 %id)
BE906841 epithelioid carcinoma, Pancreas .a 498 to 976 1 to 478       478/478
(100 %)
3 diff
(99.4 %id)
BE895455 melanotic melanoma, skin .a 498 to 1151 1 to 654       654/656
(99 %)
5 diff
(99.3 %id)
BF339790 brain, glioblastoma with EGFR amplification .a 500 to 1268 1 to 764       764/935
(81 %)
19 diff
(98.0 %id)
BG674109 skin .a 500 to 1359 1 to 865       865/868
(99 %)
22 diff
(97.5 %id)
BG831158 epithelioid carcinoma cell line, Pancreas .a 500 to 1256 1 to 758       758/770
(98 %)
10 diff
(98.8 %id)
BE314307 brain, neuroblastoma .a 501 to 1196 1 to 697       697/736
(94 %)
8 diff
(99.0 %id)
BE743330 adenocarcinoma cell line, ovary .a 501 to 968 1 to 457       457/457
(100 %)
18 diff
(96.1 %id)
BE790806 lung, small cell carcinoma .a 501 to 1072 1 to 572       572/572
(100 %)
2 diff
(99.7 %id)
BE794316 lung, small cell carcinoma .a 501 to 1259 1 to 761       761/931
(81 %)
19 diff
(98.0 %id)
BE901173 choriocarcinoma, placenta .a 501 to 1198 1 to 698       698/699
(99 %)
5 diff
(99.3 %id)
BE886461 leiomyosarcoma, uterus .a 502 to 1101 1 to 600       600/600
(100 %)
3 diff
(99.5 %id)
BE882387 leiomyosarcoma, uterus .a 502 to 1211 1 to 708       708/959
(73 %)
24 diff
(97.5 %id)
BE905839 epithelioid carcinoma, Pancreas .a 503 to 1083 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BE793545 lung, small cell carcinoma .a 504 to 1312 1 to 807       807/973
(82 %)
18 diff
(98.2 %id)
BE732916 choriocarcinoma, placenta .a 506 to 1222 1 to 711       711/713
(99 %)
11 diff
(98.5 %id)
BE733332 choriocarcinoma, placenta .a 506 to 1259 1 to 756       756/1172
(64 %)
14 diff
(98.9 %id)
BE797104 lung, small cell carcinoma .a 506 to 1259 1 to 756       756/1137
(66 %)
19 diff
(98.4 %id)
BE795964 lung, small cell carcinoma .a 508 to 1259 1 to 753       753/917
(82 %)
14 diff
(98.5 %id)
CN369440 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 509 to 950 1 to 442       442/442
(100 %)
2 diff
(99.6 %id)
BE018245 cervical carcinoma cell line, cervix .a 513 to 980 1 to 468       468/468
(100 %)
2 diff
(99.6 %id)
W04702 parathyroid gland, parathyroid tumor .a 514 to 806 1 to 287     Submitted on the opposite strand 287/287
(100 %)
16 diff
(94.5 %id)
BC024650 Kidney, hypernephroma .a 515 to 1652 1 to 1138   available from MGC, AAA   1138/1138
(100 %)
2 diff
(99.9 %id)
BE882333 leiomyosarcoma, uterus .a 517 to 1183 1 to 665       665/665
(100 %)
4 diff
(99.4 %id)
CK902289 Pancreas, Purified pancreatic islet .a 517 to 1082 1 to 566     Submitted on the opposite strand 566/566
(100 %)
3 diff
(99.5 %id)
BE559609 Burkitt lymphoma, lymph .a 518 to 1257 1 to 750       750/798
(93 %)
34 diff
(95.8 %id)
CN369447 embryonic stem cells, cell lines H1, H7, andH9 .a 521 to 662 1 to 142       142/142
(100 %)
2 diff
(98.6 %id)
BI115591 lung, small cell carcinoma .a 521 to 1283 1 to 764       764/766
(99 %)
16 diff
(98.0 %id)
BG105869 lymph, lymphoma, cell line .a 522 to 1259 1 to 733       733/813
(90 %)
19 diff
(97.7 %id)
AI826820 normal prostate, Prostate .a 523 to 942 1 to 422     Submitted on the opposite strand 422/460
(91 %)
30 diff
(93.5 %id)
BM083413 muscle, rhabdomyosarcoma .a 528 to 1144 1 to 617       617/617
(100 %)
5 diff
(99.2 %id)
BF305689 muscle, rhabdomyosarcoma .a 528 to 1108 1 to 578       578/578
(100 %)
8 diff
(98.7 %id)
BU193489 eye, retinoblastoma .a 530 to 1093 12 to 574       563/991
(56 %)
24 diff
(97.6 %id)
BU154460 eye, retinoblastoma .a 530 to 1264 12 to 758       745/939
(79 %)
30 diff
(96.9 %id)
AA807440 germinal center B cell .a 534 to 981 1 to 448     Submitted on the opposite strand 448/448
(100 %)
15 diff
(96.7 %id)
AA740819 germinal center B cell .a 534 to 955 1 to 423     Submitted on the opposite strand 423/448
(94 %)
44 diff
(90.2 %id)
AA626663 whole brain .a 536 to 1222 57 to 750       694/761
(91 %)
21 diff
(97.3 %id)
CB116591 Liver .a 539 to 775 1 to 237       237/237
(100 %)
5 diff
(97.9 %id)
BE737408 adenocarcinoma, Pancreas .a 540 to 1256 50 to 778       728/1001
(72 %)
38 diff
(96.3 %id)
BE297266 muscle, rhabdomyosarcoma .a 546 to 1174 1 to 636       636/636
(100 %)
12 diff
(98.2 %id)
AA768653 germinal center B cell .a 548 to 945 1 to 386     Submitted on the opposite strand 386/390
(98 %)
14 diff
(96.5 %id)
BE907656 epithelioid carcinoma, Pancreas .a 548 to 1163 1 to 615       615/615
(100 %)
3 diff
(99.6 %id)
AA121620 brain, neuroepithelial cells .a 562 to 911 1 to 357       355/357
(99 %)
23 diff
(93.6 %id)
AA082111   .a 586 to 812 1 to 233       233/233
(100 %)
13 diff
(94.5 %id)
BG822304 adenocarcinoma cell line, colon .a 587 to 945 1 to 361       361/546
(66 %)
11 diff
(98.0 %id)
BU860424 adenocarcinoma, cell line, breast .a 597 to 1454 1 to 858       858/858
(100 %)
5 diff
(99.5 %id)
BI084855 epidermoid carcinoma, cell line, salivary gland .a 909 to 1603 698 to 1   fully sequenced,   698/698
(100 %)
4 diff
(99.5 %id)
TI_1948105543   .a 909 to 1466 684 to 127   fully sequenced,   558/684
(81 %)
0 diff
(100 %id)
TI_1948105722   .a 909 to 1466 684 to 127   fully sequenced,   558/684
(81 %)
0 diff
(100 %id)
TI_1948121369   .a 938 to 1466 654 to 126   fully sequenced,   529/654
(80 %)
0 diff
(100 %id)
BF690174 melanotic melanoma, high MDR (cell line), skin .a 955 to 1633 676 to 2   fully sequenced,   675/676
(99 %)
1 diff
(99.9 %id)
BM662257 eye, RPE and Choroid .a 957 to 1652 712 to 18   AAA   695/696
(99 %)
1 diff
(99.9 %id)
AA129486 brain, neuroepithelial cells .a 1000 to 1651 648 to 1       648/664
(97 %)
19 diff
(97.2 %id)
AW157711 brain, frontal lobe .a 1121 to 1653 539 to 6   tiling clone,   534/539
(99 %)
11 diff
(98.0 %id)
BX426851 fetal liver, Liver .a 1126 to 1622 500 to 1       500/1065
(46 %)
17 diff
(98.5 %id)
BU951376 Pancreas, Purified pancreatic islet .a 1150 to 1653 506 to 3       504/509
(99 %)
13 diff
(97.5 %id)
BG683856 brain, neuroblastoma, cell line .a 1159 to 1601 456 to 7   fully sequenced,   450/456
(98 %)
1 diff
(99.8 %id)
AW675441 cervix .a 1256 to 1649 399 to 6       394/399
(98 %)
0 diff
(100 %id)
AA079845 Pancreas .a 1258 to 1651 397 to 1       397/426
(93 %)
5 diff
(98.9 %id)
AK225796 Kidney .b 1 to 1832 1 to 1832 M17V tiling clone, AAA   1832/1832
(100 %)
3 diff
(99.9 %id)
BE336714 Kidney, renal cell adenocarcinoma .b 27 to 192 6 to 170   tiling clone,   165/203
(81 %)
4 diff
(98.1 %id)
AU106981   .b 36 to 85 1 to 50       50/50
(100 %)
0 diff
(100 %id)
DA204148 brain .b 37 to 592 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
AW873827 Pancreas .b 39 to 316 1 to 278     Submitted on the opposite strand 278/278
(100 %)
5 diff
(98.3 %id)
AL540276 brain, fetal brain .b 44 to 968 1 to 924       924/1026
(90 %)
4 diff
(99.7 %id)
AL540184 brain, fetal brain .b 44 to 972 1 to 930   fully sequenced,   930/930
(100 %)
8 diff
(99.2 %id)
CB045645 colon, juvenile granulosa tumor .b 49 to 460 5 to 416       412/416
(99 %)
7 diff
(98.4 %id)
BF058495 fibrotheoma, ovary .b 65 to 218 1 to 154     Submitted on the opposite strand 154/154
(100 %)
6 diff
(96.2 %id)
BQ688718 ductal carcinoma, cell line, Pancreas .b 73 to 403 1 to 331       331/1293
(25 %)
6 diff
(99.6 %id)
CR984116 T-Lymphocytes .b 219 to 686 1 to 468       468/472
(99 %)
3 diff
(99.4 %id)
CA398125 eye, RPE/choroid .b 754 to 1303 1 to 550       550/550
(100 %)
1 diff
(99.9 %id)
BF962707 nervous_normal .b 785 to 1091 5 to 314       310/358
(86 %)
27 diff
(92.5 %id)
BF870344 lung_tumor .b 788 to 1082 1 to 295       295/295
(100 %)
8 diff
(97.3 %id)
AA353203   .b 793 to 957 1 to 165       165/165
(100 %)
1 diff
(99.4 %id)
BG575813 breast, mammary adenocarcinoma, cell line .b 796 to 1665 1 to 872 M17V K111S L112C F113S D114T ...     872/872
(100 %)
12 diff
(98.7 %id)
BF029673 bladder, carcinoma, cell line .b 801 to 1430 1 to 626       626/881
(71 %)
14 diff
(98.5 %id)
BG749244 eye, normal pigmented retinal epithelium .b 802 to 1704 1 to 896 M17V T164P V166C S167H L168C ...     896/899
(99 %)
24 diff
(97.4 %id)
BF527355 anaplastic oligodendroglioma with 1p/19qloss, brain .b 804 to 1439 1 to 636       636/641
(99 %)
8 diff
(98.8 %id)
BG254599 adenocarcinoma, cell line, Prostate .b 804 to 1596 1 to 798       798/948
(84 %)
38 diff
(96.0 %id)
BM558639 duodenal adenocarcinoma, cell line, small intestine .b 812 to 1761 1 to 949 M17V P264X     949/1019
(93 %)
12 diff
(98.9 %id)
BG387296 adenocarcinoma cell line, colon .b 815 to 1402 1 to 591       591/593
(99 %)
16 diff
(97.4 %id)
BG387388 adenocarcinoma cell line, colon .b 815 to 1667 1 to 861 A13C L15A A16G M17R A18G ...     859/887
(96 %)
42 diff
(95.3 %id)
AA307156 colon .b 818 to 1321 1 to 505       505/505
(100 %)
4 diff
(99.3 %id)
BG282766 adenocarcinoma, cell line, Prostate .b 820 to 1609 1 to 780       780/780
(100 %)
22 diff
(97.2 %id)
BG033639 breast, mammary adenocarcinoma, cell line .b 823 to 1426 1 to 604       604/895
(67 %)
13 diff
(98.6 %id)
TI_57228699   .b 835 to 1699 58 to 917 G12V A13R L15W A16P M17W ...     860/863
(99 %)
15 diff
(98.3 %id)
BI869882 adenocarcinoma, cell line, Liver .b 836 to 1699 1 to 859 G12V A13R L15W A16P M17W ...     859/862
(99 %)
15 diff
(98.3 %id)
BU956403 adenocarcinoma, cell line, breast .b 853 to 1705 1 to 857       857/877
(97 %)
6 diff
(99.4 %id)
BQ322617 colon_est .b 875 to 1295 1 to 421       421/421
(100 %)
25 diff
(94.1 %id)
BQ323005 colon_est .b 881 to 1372 495 to 5       491/499
(98 %)
10 diff
(98.0 %id)
BQ323008 colon_est .b 881 to 1302 1 to 422       422/422
(100 %)
12 diff
(97.2 %id)
AA429210 ovarian tumor, ovary .b 908 to 1398 1 to 498       493/507
(97 %)
8 diff
(98.5 %id)
AA224109   .b 910 to 1306 1 to 408       404/425
(95 %)
24 diff
(94.4 %id)
BE910724 epithelioid carcinoma, Pancreas .b 921 to 1536 108 to 735       498/1064
(46 %)
35 diff
(96.8 %id)
W90189 liver and spleen .b 935 to 1268 52 to 387       336/411
(81 %)
13 diff
(96.9 %id)
AL568273 brain, fetal brain .b 942 to 1769 815 to 1   fully sequenced,   815/815
(100 %)
17 diff
(98.0 %id)
BI001779 head_normal .b 947 to 1136 1 to 190       190/190
(100 %)
9 diff
(95.3 %id)
BF244227 brain, glioblastoma .b 948 to 1633 1 to 684       684/810
(84 %)
17 diff
(98.0 %id)
BF244874 brain, glioblastoma .b 948 to 1673 1 to 718       718/882
(81 %)
36 diff
(96.0 %id)
AA360501   .b 950 to 1275 1 to 326       326/326
(100 %)
0 diff
(100 %id)
AV722553 hypothalamus .b 950 to 1676 1 to 720       720/727
(99 %)
15 diff
(98.0 %id)
AV721115 hypothalamus .b 950 to 1372 1 to 419       419/425
(98 %)
6 diff
(98.6 %id)
BM020820 astrocytoma grade IV, cell line, brain .b 950 to 1750 1 to 815       815/815
(100 %)
28 diff
(96.6 %id)
BM020364 astrocytoma grade IV, cell line, brain .b 950 to 1698 1 to 748       748/748
(100 %)
12 diff
(98.4 %id)
TI_59387897   .b 951 to 1750 102 to 915       814/814
(100 %)
27 diff
(96.7 %id)
TI_59391149   .b 951 to 1698 99 to 845       747/747
(100 %)
11 diff
(98.6 %id)
BI117456 lung, small cell carcinoma .b 954 to 1778 1 to 834       834/834
(100 %)
19 diff
(97.8 %id)
BI194280 epithelioid carcinoma cell line, Pancreas .b 955 to 1598 1 to 646       646/648
(99 %)
22 diff
(96.7 %id)
BQ324964 colon_ins .b 957 to 1273 17 to 334       318/334
(95 %)
24 diff
(92.9 %id)
BQ279037 adenocarcinoma, cell line, breast .b 958 to 1824 1 to 876       876/995
(88 %)
10 diff
(99.0 %id)
M16597   .b 961 to 1699 1 to 737       737/738
(99 %)
3 diff
(99.6 %id)
BQ322868 colon_est .b 973 to 1364 392 to 1       392/392
(100 %)
2 diff
(99.5 %id)
TI_57191974   .b 974 to 1764 39 to 831       793/796
(99 %)
49 diff
(93.9 %id)
BM739330 Ascites, stomach .b 978 to 1565 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
BI001634 head_normal .b 989 to 1136 18 to 172       155/172
(90 %)
3 diff
(98.3 %id)
AL568307 brain, fetal brain .b 989 to 1803 812 to 4       809/1125
(71 %)
3 diff
(99.8 %id)
BI870057 adenocarcinoma, cell line, Liver .b 989 to 1760 1 to 773       773/774
(99 %)
3 diff
(99.7 %id)
TI_57229382   .b 989 to 1760 86 to 858       773/774
(99 %)
3 diff
(99.7 %id)
AA310448   .b 991 to 1456 1 to 467       467/467
(100 %)
2 diff
(99.6 %id)
BE273582 Kidney, renal cell adenocarcinoma .b 1003 to 1456 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BE294960 muscle, rhabdomyosarcoma .b 1006 to 1594 1 to 598       575/627
(91 %)
17 diff
(97.3 %id)
FN135581 breast carcinoma .b 1028 to 1122 98 to 2     Submitted on the opposite strand 97/98
(98 %)
0 diff
(100 %id)
N85389   .b 1042 to 1402 1 to 356       356/356
(100 %)
5 diff
(98.6 %id)
N88268   .b 1042 to 1244 1 to 201       201/201
(100 %)
3 diff
(98.6 %id)
BE931274 head_neck .b 1066 to 1182 131 to 13       119/143
(83 %)
5 diff
(96.6 %id)
CD613356   .b 1069 to 1278 219 to 11       210/220
(95 %)
2 diff
(99.1 %id)
AA308594 retina .b 1071 to 1399 1 to 329       329/329
(100 %)
0 diff
(100 %id)
CU444597 epidermis .b 1073 to 1517 1 to 447       445/449
(99 %)
9 diff
(98.0 %id)
CU445397 epidermis .b 1073 to 1517 447 to 3     Submitted on the opposite strand 445/449
(99 %)
4 diff
(99.2 %id)
CU445570 epidermis .b 1073 to 1517 447 to 3     Submitted on the opposite strand 445/449
(99 %)
5 diff
(98.9 %id)
CU451787 epidermis .b 1073 to 1517 447 to 3     Submitted on the opposite strand 445/449
(99 %)
3 diff
(99.4 %id)
CU455664 epidermis .b 1073 to 1517 1 to 447       445/449
(99 %)
9 diff
(98.0 %id)
CU450139 epidermis .b 1074 to 1517 446 to 3     Submitted on the opposite strand 444/448
(99 %)
3 diff
(99.4 %id)
CD613357   .b 1075 to 1284 1 to 217       217/223
(97 %)
3 diff
(98.7 %id)
CV371791 colon_ins .b 1093 to 1316 15 to 235       221/236
(93 %)
11 diff
(95.4 %id)
CV371833 colon_ins .b 1093 to 1316 15 to 235       221/236
(93 %)
11 diff
(95.4 %id)
BF170147 blood .b 1097 to 1388 1 to 290       290/297
(97 %)
3 diff
(99.0 %id)
CV395679 lung_tumor .b 1105 to 1390 429 to 144     Submitted on the opposite strand 286/429
(66 %)
5 diff
(98.9 %id)
AW796095 uterus .b 1109 to 1303 221 to 25       197/224
(87 %)
6 diff
(97.4 %id)
CV367659 colon_normal .b 1112 to 1354 33 to 275       243/287
(84 %)
15 diff
(94.8 %id)
AA356862   .b 1115 to 1386 1 to 272       272/272
(100 %)
0 diff
(100 %id)
BQ350102 head_neck .b 1118 to 1437 25 to 341       317/346
(91 %)
7 diff
(98.0 %id)
AA373810 lung .b 1133 to 1495 1 to 368       368/370
(99 %)
9 diff
(97.6 %id)
BQ354705 head_neck .b 1136 to 1491 356 to 1       356/356
(100 %)
1 diff
(99.8 %id)
AA363763 pineal body .b 1137 to 1393 1 to 258       258/258
(100 %)
1 diff
(99.7 %id)
AW577799 breast .b 1138 to 1397 53 to 300       248/300
(82 %)
17 diff
(94.4 %id)
AA248700   .b 1153 to 1291 1 to 139       139/139
(100 %)
0 diff
(100 %id)
FN167277 breast carcinoma .b 1157 to 1240 1 to 84       84/84
(100 %)
2 diff
(97.7 %id)
EC528169 Prostate .b 1165 to 1268 102 to 1       102/102
(100 %)
2 diff
(98.1 %id)
BF808429 colon_ins .b 1166 to 1345 203 to 21     Submitted on the opposite strand 183/204
(89 %)
2 diff
(99.1 %id)
BG290767 bladder, transitional cell papilloma, cell line .b 1166 to 1412 40 to 284       245/286
(85 %)
9 diff
(96.9 %id)
FN063105 breast carcinoma .b 1177 to 1239 63 to 1     Submitted on the opposite strand 63/63
(100 %)
0 diff
(100 %id)
AA220218   .b 1206 to 1500 1 to 293       293/300
(97 %)
9 diff
(97.0 %id)
N58634 liver and spleen .b 1207 to 1545 1 to 341       341/349
(97 %)
5 diff
(98.6 %id)
AW385621 leiomios .b 1210 to 1351 15 to 152       138/152
(90 %)
10 diff
(93.5 %id)
DW443494 Liver .b 1213 to 1426 17 to 230       214/230
(93 %)
9 diff
(96.1 %id)
N46524 multiple sclerosis lesions .b 1324 to 1524 1 to 201       201/201
(100 %)
6 diff
(97.1 %id)
BQ349337 head_neck .b 1332 to 1539 221 to 15       211/221
(95 %)
0 diff
(100 %id)
CV347777 lung_normal .b 1335 to 1533 1 to 199       199/205
(97 %)
7 diff
(96.6 %id)
FN124236 breast carcinoma .b 1356 to 1459 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
EC570122 Prostate .b 1377 to 1471 1 to 96       96/96
(100 %)
4 diff
(95.9 %id)
CB045644 colon, juvenile granulosa tumor .b 1382 to 1832 467 to 17   AAA   451/451
(100 %)
0 diff
(100 %id)
FN067660 breast carcinoma .b 1383 to 1474 92 to 1     Submitted on the opposite strand 92/92
(100 %)
7 diff
(92.4 %id)
W90071 liver and spleen .b 1409 to 1833 429 to 4       426/429
(99 %)
0 diff
(100 %id)
FN099243 breast carcinoma .b 1451 to 1533 80 to 1     Submitted on the opposite strand 80/81
(98 %)
3 diff
(96.3 %id)
AA224363   .b 1538 to 1830 293 to 1       293/294
(99 %)
4 diff
(98.7 %id)
FN057917 breast carcinoma .b 1539 to 1625 87 to 1     Submitted on the opposite strand 87/87
(100 %)
0 diff
(100 %id)
TI_1948105363   .b 1545 to 1646 226 to 125       102/126
(80 %)
0 diff
(100 %id)
BU165817 melanotic melanoma, skin .b 1569 to 1832 1 to 264   AAA   264/264
(100 %)
0 diff
(100 %id)
BM824164 Ascites, stomach .b 1596 to 1832 1 to 237   AAA   237/237
(100 %)
0 diff
(100 %id)
BM856355 stomach .b 1609 to 1832 1 to 224   AAA   224/224
(100 %)
0 diff
(100 %id)
BM830030 stomach .b 1609 to 1832 1 to 224   AAA   224/224
(100 %)
0 diff
(100 %id)
ES312225 frontal balding hair, skin .b 1615 to 1832 1 to 211   AAA   211/211
(100 %)
6 diff
(97.2 %id)
F30184 pectoral muscle (after mastectomy) .b 1618 to 1820 1 to 203       203/203
(100 %)
0 diff
(100 %id)
FN069692 breast carcinoma .b 1663 to 1761 1 to 98       98/98
(100 %)
1 diff
(99.0 %id)
AA401743   .b 1681 to 1830 154 to 1       154/169
(91 %)
7 diff
(95.9 %id)
FN141997 breast carcinoma .b 1691 to 1782 12 to 103       92/103
(89 %)
6 diff
(94.2 %id)
FN112546 breast carcinoma .b 1704 to 1803 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
AI972923 Prostate .b 1704 to 1832 129 to 1       129/129
(100 %)
0 diff
(100 %id)
AI686244 Prostate .b 1705 to 1832 138 to 11   AAA   128/128
(100 %)
0 diff
(100 %id)
BF821301 kidney_tumor .c 1 to 164 164 to 1   tiling clone, Submitted on the opposite strand 164/164
(100 %)
0 diff
(100 %id)
AA309025 colon .c 132 to 674 1 to 544   tiling clone,   544/544
(100 %)
3 diff
(99.5 %id)
AA309026 colon .c 132 to 577 1 to 451       451/451
(100 %)
9 diff
(98.1 %id)
AW955457   .c 133 to 693 1 to 557   tiling clone,   557/591
(94 %)
22 diff
(96.3 %id)
CU446155 epidermis .c 242 to 407 1 to 166       166/166
(100 %)
3 diff
(98.2 %id)
T60831 ovary .c 572 to 801 1 to 240   tiling clone, fully sequenced,   240/240
(100 %)
3 diff
(98.8 %id)
T60780 ovary .c 771 to 1017 248 to 1   tiling clone, fully sequenced,   248/248
(100 %)
5 diff
(98.0 %id)
TI_159678275   .d 1 to 856 919 to 65 F2* tiling clone,   855/1107
(77 %)
21 diff
(98.2 %id)
BU538456 adenocarcinoma, cell line, breast .d 11 to 853 30 to 872       843/985
(85 %)
13 diff
(98.7 %id)
BG826373 muscle, rhabdomyosarcoma .d 14 to 858 1 to 851       851/861
(98 %)
13 diff
(98.5 %id)
BI114597 muscle, rhabdomyosarcoma .d 14 to 776 1 to 766       766/766
(100 %)
9 diff
(98.9 %id)
BG119029 adenocarcinoma, cell line, Liver .d 15 to 825 1 to 802       802/919
(87 %)
33 diff
(96.5 %id)
BG117391 adenocarcinoma, cell line, Liver .d 18 to 699 1 to 681       681/932
(73 %)
7 diff
(99.3 %id)
BC033076 Skin, melanoma, amelanotic .d 24 to 858 619 to 1460   tiling clone, available from MGC, AAA   842/1460
(57 %)
3 diff
(99.8 %id)
BU934717 mixed (pool of 40 RNAs) .d 27 to 800 1 to 785       785/791
(99 %)
23 diff
(97.1 %id)
BE296554 muscle, rhabdomyosarcoma .d 32 to 599 1 to 568       568/568
(100 %)
0 diff
(100 %id)
BM794508 Ascites, stomach .d 42 to 691 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
BI116156 lung, small cell carcinoma .d 47 to 765 1 to 720       720/720
(100 %)
2 diff
(99.8 %id)
CX762768 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .d 47 to 781 34 to 775     Submitted on the opposite strand 742/775
(95 %)
4 diff
(99.5 %id)
BM802665 embryonal carcinoma, cell line, testis .d 51 to 858 10 to 824   AAA   815/824
(98 %)
9 diff
(99.0 %id)
AI567476 anaplastic oligodendroglioma, brain .d 53 to 858 803 to 1       804/803
(100 %)
17 diff
(97.9 %id)
BE881318 large cell carcinoma, undifferentiated, lung .d 56 to 858 1 to 795       795/866
(91 %)
26 diff
(97.0 %id)
BE548458 cervical carcinoma cell line, cervix .d 75 to 785 1 to 703       703/894
(78 %)
16 diff
(98.3 %id)
BE794170 lung, small cell carcinoma .d 75 to 847 1 to 768       768/768
(100 %)
8 diff
(99.0 %id)
TI_149292478   .d 85 to 858 837 to 80   AAA   758/875
(86 %)
22 diff
(97.5 %id)
BG424164 Kidney, renal cell adenocarcinoma .d 90 to 837 1 to 748       748/749
(99 %)
13 diff
(98.3 %id)
BE783456 eye, retinoblastoma .d 92 to 858 1 to 761       761/767
(99 %)
16 diff
(98.0 %id)
BG424575 Kidney, renal cell adenocarcinoma .d 96 to 678 1 to 583       583/584
(99 %)
4 diff
(99.4 %id)
BQ574597 Chondrosarcoma Grade II, Left Pelvis .d 107 to 860 772 to 19   AAA   754/754
(100 %)
4 diff
(99.5 %id)
BQ447370 Knee, Osteoarthritic Cartilage .d 110 to 858 760 to 19   AAA   742/742
(100 %)
11 diff
(98.6 %id)
BQ574718 Chondrosarcoma Grade II, Left Pelvis .d 117 to 858 767 to 19   AAA   749/749
(100 %)
8 diff
(99.0 %id)
AJ710819 heart .d 121 to 649 1 to 529       529/529
(100 %)
1 diff
(99.9 %id)
CX786435 human embryonic stem cells .d 130 to 859 736 to 7     Submitted on the opposite strand 730/736
(99 %)
2 diff
(99.8 %id)
AA911753 pooled germ cell tumors .d 135 to 814 667 to 1       669/677
(98 %)
63 diff
(90.7 %id)
TI_149296821   .d 135 to 858 814 to 97   AAA   718/814
(88 %)
16 diff
(98.1 %id)
BF971042 adrenal cortex carcinoma, cell line, adrenal gland .d 140 to 858 15 to 737       723/928
(77 %)
15 diff
(98.4 %id)
BU682423 lung .d 140 to 858 729 to 19   AAA   711/722
(98 %)
16 diff
(97.8 %id)
TI_149299477   .d 142 to 857 810 to 93       718/1056
(67 %)
7 diff
(99.4 %id)
CA309151 Alveolar Macrophage, lung .d 144 to 858 736 to 19   AAA   718/722
(99 %)
6 diff
(99.2 %id)
BE560743 Burkitt lymphoma, lymph .d 146 to 853 1 to 713   AAA   713/713
(100 %)
10 diff
(98.6 %id)
BQ675252 epidermoid carcinoma, cell line, salivary gland .d 146 to 859 1 to 719       719/924
(77 %)
14 diff
(98.5 %id)
BM824528 Ascites, stomach .d 150 to 698 1 to 549       549/549
(100 %)
0 diff
(100 %id)
BM693790 eye, lens .d 150 to 495 1 to 346   fully sequenced,   346/346
(100 %)
0 diff
(100 %id)
BF340431 brain, glioblastoma with EGFR amplification .d 151 to 715 1 to 565       565/565
(100 %)
3 diff
(99.5 %id)
TI_57190859   .d 151 to 859 55 to 764       710/774
(91 %)
5 diff
(99.4 %id)
BU733985 eye, Retina Foveal and Macular .d 151 to 858 728 to 19   AAA   710/714
(99 %)
9 diff
(98.8 %id)
AI683374 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 152 to 859 706 to 1       708/706
(100 %)
8 diff
(98.9 %id)
AI936067 normal prostate, Prostate .d 152 to 859 707 to 2       706/707
(99 %)
8 diff
(98.9 %id)
BG397599 B-cells, primary B-cells from tonsils (cell line) .d 152 to 861 1 to 711       711/731
(97 %)
2 diff
(99.8 %id)
BI857686 breast, mammary adenocarcinoma, cell line .d 152 to 859 1 to 709       709/722
(98 %)
5 diff
(99.4 %id)
TI_149304935   .d 155 to 853 785 to 86   AAA   700/901
(77 %)
9 diff
(99.1 %id)
CA306243 Alveolar Macrophage, lung .d 155 to 858 722 to 19   AAA   704/704
(100 %)
0 diff
(100 %id)
CA428537 cell lines, Chondrosarcoma .d 159 to 858 720 to 19   AAA   702/702
(100 %)
2 diff
(99.8 %id)
BM692681 eye, Retina Foveal and Macular .d 160 to 700 1 to 541       541/541
(100 %)
1 diff
(99.9 %id)
AI963295 adenocarcinoma, Pancreas .d 162 to 858 696 to 1       696/696
(100 %)
9 diff
(98.8 %id)
AI954064 normal epithelium, ovary .d 163 to 858 698 to 1       698/698
(100 %)
7 diff
(99.0 %id)
BU528393 epidermoid carcinoma, cell line, lung .d 163 to 857 725 to 25     Submitted on the opposite strand 701/934
(75 %)
10 diff
(99.0 %id)
BU631347 cell lines, Chondrosarcoma .d 164 to 858 708 to 19   AAA   690/690
(100 %)
7 diff
(99.0 %id)
CB528970 Aveolar Macrophage, lung .d 165 to 858 710 to 19   AAA   692/692
(100 %)
2 diff
(99.8 %id)
BM975802 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 167 to 857 711 to 21       691/711
(97 %)
0 diff
(100 %id)
CA425834 cell lines, Chondrosarcoma .d 169 to 858 708 to 19   AAA   690/690
(100 %)
1 diff
(99.9 %id)
AW043843 pooled .d 177 to 857 679 to 1       679/679
(100 %)
5 diff
(99.3 %id)
TI_149275456   .d 179 to 858 733 to 57   AAA   677/697
(97 %)
8 diff
(98.9 %id)
CA418498 Chondrosarcoma Grade II, Left Pelvis .d 180 to 858 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
CD368512 Alveolar Macrophage, lung .d 180 to 858 697 to 19   AAA   679/679
(100 %)
0 diff
(100 %id)
AA456173 ovarian tumor, ovary .d 188 to 596 1 to 408   fully sequenced,   408/408
(100 %)
2 diff
(99.6 %id)
AA100976 Pancreas .d 191 to 530 1 to 343   fully sequenced,   343/343
(100 %)
4 diff
(98.9 %id)
BM978432 lung, Primary Lung Epithelial Cells .d 196 to 853 678 to 19   AAA   660/660
(100 %)
2 diff
(99.7 %id)
AA191011   .d 199 to 530 1 to 331   fully sequenced,   331/331
(100 %)
1 diff
(99.7 %id)
CD367839 Alveolar Macrophage, lung .d 202 to 858 675 to 19   AAA   657/657
(100 %)
0 diff
(100 %id)
BP429033   .d 216 to 580 1 to 365       365/365
(100 %)
0 diff
(100 %id)
BF029876 hypernephroma, Kidney .d 219 to 630 1 to 412       412/412
(100 %)
0 diff
(100 %id)
BM792371 Ascites, stomach .d 219 to 771 1 to 552       552/552
(100 %)
1 diff
(99.9 %id)
BG470972 eye, retinoblastoma .d 222 to 860 1 to 640   AAA   640/640
(100 %)
7 diff
(99.0 %id)
AA453948   .d 230 to 530 1 to 301   fully sequenced,   301/301
(100 %)
0 diff
(100 %id)
BG779028 adenocarcinoma, Prostate .d 231 to 650 1 to 420       420/420
(100 %)
0 diff
(100 %id)
BU196090 melanotic melanoma, cell line, skin .d 234 to 858 1 to 625   AAA   625/625
(100 %)
0 diff
(100 %id)
CD369041 Alveolar Macrophage, lung .d 234 to 858 643 to 19   AAA   625/625
(100 %)
1 diff
(99.9 %id)
CV377162 colon_ins .d 236 to 785 555 to 7     Submitted on the opposite strand 549/555
(98 %)
4 diff
(99.3 %id)
BU069322 Pancreas, Purified pancreatic islet .d 236 to 858 623 to 1       623/623
(100 %)
2 diff
(99.7 %id)
BM665355 eye, Retina Foveal and Macular .d 256 to 858 623 to 19   AAA   605/605
(100 %)
6 diff
(99.1 %id)
AI634917 adenocarcinoma, Pancreas .d 260 to 858 597 to 1       692/728
(95 %)
20 diff
(97.3 %id)
BF718704 epidermis, foreskin .d 265 to 853 590 to 2       589/590
(99 %)
2 diff
(99.7 %id)
BM771578 stomach .d 270 to 847 1 to 578       578/578
(100 %)
0 diff
(100 %id)
AI687973 pooled .d 292 to 859 571 to 4       568/571
(99 %)
0 diff
(100 %id)
BQ286776 Pancreas, Purified pancreatic islet .d 304 to 663 358 to 1       358/358
(100 %)
42 diff
(88.3 %id)
BU181623 epithelioid carcinoma, Pancreas .d 304 to 858 605 to 44   AAA Submitted on the opposite strand 562/811
(69 %)
12 diff
(98.6 %id)
BM691991 eye, human retina .d 304 to 530 1 to 227   fully sequenced,   227/227
(100 %)
3 diff
(98.7 %id)
BF791939 adrenal cortex carcinoma, cell line, adrenal gland .d 312 to 858 1 to 547   AAA   547/547
(100 %)
0 diff
(100 %id)
AI187187 lung .d 317 to 859 541 to 1       541/541
(100 %)
2 diff
(99.7 %id)
BM752376 Ascites, stomach .d 323 to 833 1 to 512       512/512
(100 %)
1 diff
(99.9 %id)
AA836939 Kidney, kidney tumor .d 329 to 806 480 to 1       480/489
(98 %)
17 diff
(96.6 %id)
BU615643 Bone, Enchondroma cell line .d 330 to 858 548 to 19   AAA   530/530
(100 %)
1 diff
(99.9 %id)
BU684457 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 348 to 858 530 to 19   AAA   512/512
(100 %)
1 diff
(99.9 %id)
BU624322 cell lines, Enchondroma .d 349 to 858 530 to 19   AAA   512/512
(100 %)
4 diff
(99.3 %id)
BQ421140 epithelioid carcinoma, Pancreas .d 350 to 858 1 to 509       509/577
(88 %)
1 diff
(99.9 %id)
AW005807 anaplastic oligodendroglioma, brain .d 352 to 858 506 to 1       506/510
(99 %)
1 diff
(99.9 %id)
CV347794 lung_normal .d 361 to 679 317 to 1     Submitted on the opposite strand 317/317
(100 %)
3 diff
(99.1 %id)
CV347806 lung_normal .d 361 to 679 317 to 1     Submitted on the opposite strand 317/317
(100 %)
2 diff
(99.4 %id)
CV347825 lung_normal .d 361 to 679 317 to 1     Submitted on the opposite strand 317/317
(100 %)
4 diff
(98.8 %id)
CV347831 lung_normal .d 361 to 677 330 to 16     Submitted on the opposite strand 315/330
(95 %)
0 diff
(100 %id)
CV347840 lung_normal .d 361 to 681 321 to 3     Submitted on the opposite strand 319/321
(99 %)
0 diff
(100 %id)
BP385610 pancreatic islet .d 363 to 843 1 to 481     Submitted on the opposite strand 481/481
(100 %)
1 diff
(99.8 %id)
BQ962935 epithelioid carcinoma cell line, Pancreas .d 363 to 858 1 to 496   AAA   496/496
(100 %)
0 diff
(100 %id)
AI953037 pooled germ cell tumors .d 366 to 859 497 to 4       494/497
(99 %)
2 diff
(99.6 %id)
BM912793 amelanotic melanoma, cell line, skin .d 367 to 761 404 to 10     Submitted on the opposite strand 395/1473
(26 %)
9 diff
(99.4 %id)
BG059544 brain, glioblastoma without EGFR amplification .d 368 to 858 492 to 1       492/492
(100 %)
4 diff
(99.2 %id)
DB576653 hypothalamus .d 371 to 857 1 to 487     Submitted on the opposite strand 487/488
(99 %)
3 diff
(99.4 %id)
AI078786 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 371 to 858 488 to 1       488/488
(100 %)
0 diff
(100 %id)
BP385164 pancreatic islet .d 375 to 857 1 to 484     Submitted on the opposite strand 484/484
(100 %)
2 diff
(99.6 %id)
EL951559 eyeball .d 379 to 812 1 to 434       434/434
(100 %)
3 diff
(99.4 %id)
AA304309 aorta .d 389 to 659 1 to 271       271/271
(100 %)
0 diff
(100 %id)
AA626399 lung, lung carcinoma .d 392 to 859 471 to 7     Submitted on the opposite strand 465/471
(98 %)
6 diff
(98.8 %id)
AI433702 Kidney .d 393 to 858 466 to 1       466/466
(100 %)
0 diff
(100 %id)
BQ773921 Chondrosarcoma Grade II, Left Pelvis .d 399 to 858 479 to 19   AAA   461/461
(100 %)
1 diff
(99.8 %id)
AW772490 Kidney .d 405 to 859 457 to 3       455/457
(99 %)
0 diff
(100 %id)
EL949073 eyeball .d 406 to 796 1 to 396       396/396
(100 %)
8 diff
(98.0 %id)
AI127054 heart .d 406 to 858 471 to 19   AAA   453/453
(100 %)
1 diff
(99.8 %id)
TI_159724101   .d 415 to 858 505 to 62   AAA   444/1055
(42 %)
0 diff
(100 %id)
AI301862 2 pooled tumors (clear cell type), Kidney .d 418 to 856 439 to 1       439/448
(97 %)
48 diff
(89.3 %id)
AA427430 ovarian tumor, ovary .d 423 to 858 436 to 1       436/436
(100 %)
1 diff
(99.8 %id)
BU738230 eye, lens .d 434 to 858 443 to 19   fully sequenced, AAA   425/425
(100 %)
0 diff
(100 %id)
BG259242 embryonal carcinoma, cell line, testis .d 443 to 858 1 to 416   AAA   416/416
(100 %)
0 diff
(100 %id)
W31804 parathyroid gland, parathyroid tumor .d 446 to 858 433 to 17   AAA Submitted on the opposite strand 417/417
(100 %)
9 diff
(97.9 %id)
BM825423 Ascites, stomach .d 455 to 858 1 to 404   AAA   404/404
(100 %)
0 diff
(100 %id)
TI_154177560   .d 456 to 858 57 to 460       404/862
(46 %)
10 diff
(98.9 %id)
TI_154173417   .d 459 to 858 79 to 478   AAA   400/400
(100 %)
9 diff
(97.8 %id)
AI865407 lymph node, lymphoma, follicular mixed small and largecell .d 465 to 850 393 to 7       387/393
(98 %)
14 diff
(96.5 %id)
F26065 pectoral muscle (after mastectomy) .d 470 to 775 1 to 306       306/306
(100 %)
0 diff
(100 %id)
DB559633 hypothalamus .d 471 to 857 1 to 388     Submitted on the opposite strand 388/389
(99 %)
4 diff
(99.0 %id)
BI010403 lung_normal .d 478 to 678 202 to 2       201/202
(99 %)
0 diff
(100 %id)
CF145355 CNCAP(3)T-225 cell line, Prostate .d 492 to 854 1 to 363       363/363
(100 %)
0 diff
(100 %id)
AA100977 Pancreas .d 500 to 859 361 to 2   fully sequenced,   360/361
(99 %)
0 diff
(100 %id)
AA191474   .d 500 to 859 362 to 4   fully sequenced,   359/362
(99 %)
0 diff
(100 %id)
AA453445   .d 500 to 858 393 to 35   fully sequenced, AAA   359/359
(100 %)
0 diff
(100 %id)
BU728484 eye, human retina .d 500 to 858 377 to 19   fully sequenced, AAA   359/359
(100 %)
0 diff
(100 %id)
BM705130 eye, RPE and Choroid .d 501 to 858 1 to 358   AAA   358/358
(100 %)
0 diff
(100 %id)
AA196871 muscle, skeletal muscle .d 508 to 855 1 to 347       347/347
(100 %)
1 diff
(99.8 %id)
EC567224 Prostate .d 514 to 586 72 to 1       72/72
(100 %)
1 diff
(98.7 %id)
BQ324162 colon_ins .d 516 to 734 221 to 1       221/221
(100 %)
9 diff
(96.0 %id)
TI_149306522   .d 516 to 857 433 to 92       342/433
(78 %)
0 diff
(100 %id)
AI580855 pooled germ cell tumors .d 518 to 858 341 to 1       341/341
(100 %)
0 diff
(100 %id)
BM129705 Islets of Langerhans, Pancreas .d 521 to 858 1 to 338   fully sequenced, AAA   338/338
(100 %)
0 diff
(100 %id)
EC442358 Prostate .d 522 to 611 1 to 90       90/90
(100 %)
5 diff
(94.5 %id)
EC528910 Prostate .d 524 to 611 1 to 88       88/88
(100 %)
2 diff
(97.8 %id)
BE742690 adenocarcinoma cell line, ovary .d 525 to 856 1 to 332       332/332
(100 %)
0 diff
(100 %id)
BE740372 adenocarcinoma cell line, ovary .d 526 to 856 1 to 331       331/331
(100 %)
0 diff
(100 %id)
AA443108 ovarian tumor, ovary .d 535 to 857 323 to 1   fully sequenced,   323/323
(100 %)
2 diff
(99.4 %id)
BM129416 Islets of Langerhans, Pancreas .d 641 to 866 227 to 2   fully sequenced,   226/227
(99 %)
5 diff
(97.8 %id)
BQ669152 epidermoid carcinoma, cell line, salivary gland .e 1 to 739 1 to 744   tiling clone,   744/937
(79 %)
21 diff
(97.8 %id)
BG180799 adenocarcinoma, cell line, Prostate .e 542 to 1271 1 to 721 K199S tiling clone,   721/951
(75 %)
16 diff
(98.4 %id)
BE396497 Burkitt lymphoma, lymph .e 543 to 1220 1 to 674 V177X Y178L T179H I180H R182A ... tiling clone,   674/748
(90 %)
4 diff
(99.5 %id)
BQ354591 head_neck .f 1 to 479 1 to 401   tiling clone,   355/401
(88 %)
28 diff
(93.1 %id)
BQ322953 colon_est .f 57 to 433 377 to 1   tiling clone,   377/377
(100 %)
4 diff
(99.0 %id)
CU457177 epidermis .f 85 to 525 1 to 441   tiling clone,   441/445
(99 %)
8 diff
(98.3 %id)
CU443006 epidermis Gene CYC1, variant not shown         This clone was ignored    
CU448959 epidermis Gene CYC1, variant not shown         This clone was ignored    
CU449047 epidermis Gene CYC1, variant not shown         This clone was ignored    
CU449481 epidermis Gene CYC1, variant not shown         This clone was ignored    
CU450819 epidermis Gene CYC1, variant not shown         This clone was ignored    
CU450972 epidermis Gene CYC1, variant not shown         Submitted on the opposite strand    
CU451116 epidermis Gene CYC1, variant not shown         This clone was ignored    
CU451121 epidermis Gene CYC1, variant not shown         Submitted on the opposite strand    
CU452375 epidermis Gene CYC1, variant not shown         This clone was ignored    
CU452863 epidermis Gene CYC1, variant not shown         Submitted on the opposite strand    
CU454035 epidermis Gene CYC1, variant not shown         This clone was ignored    
CU454356 epidermis Gene CYC1, variant not shown         Submitted on the opposite strand    
CU456735 epidermis Gene CYC1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI